This inventor holds 29 USPTO granted patents and 13 published patent applications, plus 6 CIPO patents and 14 EPO patents, primarily in Protein Kinase Inhibitors. Top assignees: Astex Therapeutics Limited, Glaxosmithkline Intellectual Property Development Limited, Otsuka Pharmaceutical Company, Limited. Active years: 2008-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Cambridgeshire, GB (2018 - 2019)
- Cambridge, GB (2008 - 2024)
Company Filing History:
26 out of 126 
6 out of 242 
3 out of 846 
Years Active: 2008-2024
Areas of Expertise:
Title: Alison Jo-Anne Woolford: Innovator in Therapeutic Compounds
Introduction
Alison Jo-Anne Woolford, based in Cambridge, GB, is a prominent inventor known for her significant contributions to the field of medicinal chemistry. With a remarkable portfolio of 29 patents, Woolford's work focuses primarily on the development of innovative compounds aimed at treating various medical conditions, particularly cancer.
Latest Patents
Among her notable inventions are the following patents:
1. **Benzolactam Compounds as Protein Kinase Inhibitors** - This invention presents a compound formula that serves as inhibitors of ERK1/2 kinases. These compounds are particularly promising for the treatment of conditions mediated by ERK1/2, positioning them as valuable therapeutic options in cancer treatment.
2. **Bicyclic Heterocycle Compounds and Their Uses in Therapy** - This patent discusses bicyclic heterocycle compounds and their various forms, including N-oxides and pharmaceutically acceptable salts. The compounds outlined within this patent are designed for use in treating diseases such as cancer, thereby expanding the potential therapeutic landscape.
Career Highlights
Throughout her career, Alison Woolford has showcased her expertise by working with reputable firms such as Astex Therapeutics Limited and GlaxoSmithKline Intellectual Property Development Limited. Her innovative spirit and dedication have been pivotal in the advancement of therapeutic solutions.
Collaborations
Alison has collaborated with esteemed colleagues, including Andrew James Woodhead and Thomas Daniel Heightman. These partnerships have likely enhanced her research capabilities and contributed to her impressive patent portfolio.
Conclusion
Alison Jo-Anne Woolford stands out as a key figure in the development of therapeutic compounds through her extensive patent work. Her contributions are significant in the pursuit of effective treatments for cancer and other serious conditions. As she continues her innovative journey, the medical field awaits the potential impact of her future inventions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile